Agios Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Agios Pharmaceuticals Inc
TickerAGIO
CIK #0001439222
CUSIP00847X104
SectorLife Sciences - Pharmaceutical Preparations
Address38 Sidney Street 2Nd Floor, Cambridge, MA 02139
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Agios Pharmaceuticals Inc 2011-11-22 78.0 M Exemption: 506 · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001439222] 10-K
[0001439222] 10-Q
[0001439222] 3
[0001439222] 4
[0001439222] 5
[0001439222] 8-K
[0001439222] SC 13D
[0001439222] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
D E Shaw & Co LP Agios Pharmaceuticals Inc [2026-07-02] 0.0
Lynx1 Capital Management LP Agios Pharmaceuticals Inc [2026-05-06] 0.0
Vanguard Capital Management LLC Agios Pharmaceuticals Inc [2026-04-29] 0.0
Armistice Capital LLC Agios Pharmaceuticals Inc [2026-02-17] 0.0
State Street Corp Agios Pharmaceuticals Inc [2026-02-09] 0.0
Bellevue Group AG Agios Pharmaceuticals Inc [2025-07-07] 0.0
Farallon Capital Partners LP Agios Pharmaceuticals Inc [2023-11-09] 0.6
Armistice Capital LLC Agios Pharmaceuticals Inc [2023-02-14] 5.01
Rock Springs Capital Management LP Agios Pharmaceuticals Inc [2023-02-14] 5.45
Price T Rowe Associates Inc /MD/ Agios Pharmaceuticals Inc [2022-02-14] 5.3
State Street Corp Agios Pharmaceuticals Inc [2022-02-09] 5.51
JPMorgan Chase & Co Agios Pharmaceuticals Inc [2022-01-19] 5.7
BlackRock Inc Agios Pharmaceuticals Inc [2020-02-07] 5.8
BlackRock Inc Agios Pharmaceuticals Inc [2018-02-01] 5.8
Vanguard Group Inc Agios Pharmaceuticals Inc [2017-02-09] 5.87
BlackRock Inc Agios Pharmaceuticals Inc [2017-01-30] 5.1
Capital International Investors Agios Pharmaceuticals Inc [2016-02-12] 5.7
Vanguard Specialized Funds Agios Pharmaceuticals Inc [2016-02-09] 6.7
Capital World Investors Agios Pharmaceuticals Inc [2015-02-13] 8.4
Wellington Management Group LLP Agios Pharmaceuticals Inc [2015-02-12] 5.5
BB Biotech AG Agios Pharmaceuticals Inc [2014-09-11] 5.1
Third Rock Ventures LP Agios Pharmaceuticals Inc [2014-02-12] 17.9
Flagship Ventures Fund 2007 LP Agios Pharmaceuticals Inc [2014-02-10] 12.4
Arch Venture Fund VII LP Agios Pharmaceuticals Inc [2014-02-06] 12.4
FMR LLC Agios Pharmaceuticals Inc [2013-11-12] 0.0
Celgene European Investment Co LLC Agios Pharmaceuticals Inc [2013-08-06] 13.3
Form 3/4/5 Filer 2011 - 2026
Gheuens Sarah
Agios Pharmaceuticals Inc
Backstrom Jay T
Owen Adams Catherine
Jones Cecilia
Ballal Rahul D
Capello Jeffrey D
Foster-Cheek Kaye I
Fouse Jacqualyn A
Ho Maykin
Milanova Tsveta
Scadden David
Smith Cynthia
Viswanadhan Krishnan
Goff Brian
Burns James William
Washburn Theodore James Jr
Schenkein David P
Maraganore John
Poddar Richa
Clancy Paul J
Clark Ian T
Biller Jonathan
Car Bruce
Alenson Carman
Bowden Christopher
Miles Darrin
Hirsch Andrew
Celgene Switzerland LLC
Celgene European Investment Co LLC
Celgene Alpine Investment Co LLC
Celgene Corp /DE/
Biller Scott
Hoerter Steven L
Cantley Lewis Clayton Jr
Nelsen Robert
Cole Douglas G
Tessier-Lavigne Marc
Goddard Glenn
Higgons John Duncan
Karsen Perry A
Bybee Clinton
Arch Venture Fund VII LP
Crandell Keith
Arch Venture Partners VII LP
Arch Venture Partners VII LLC
Starr Kevin P
Third Rock Ventures LP
TRV GP LLC
Third Rock Ventures GP LP
Flagship Ventures 2007 General Partner LLC
Afeyan Noubar
Flagship Ventures Fund 2007 LP
Kania Edwin
Mak Tak W
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Viswanadhan Krishnan
Common stock
2026-03-05 Sell 2,959 $27.80 82,260
Viswanadhan Krishnan
Common stock
2026-03-05 Option exercise 8,100 $0.00
Viswanadhan Krishnan
Restricted stock units · derivative
2026-03-05 Option exercise 8,100 $0.00
Washburn Theodore James Jr
Common stock
2026-03-03 Sell 5,272 $28.88 152,255
Burns James William
Common stock
2026-03-02 Option exercise 4,000 $0.00
Burns James William
Restricted stock units · derivative
2026-03-02 Option exercise 3,920 $0.00
Burns James William
Restricted stock units · derivative
2026-03-02 Option exercise 4,000 $0.00
Milanova Tsveta
Restricted stock units · derivative
2026-03-02 Option exercise 4,000 $0.00
Gheuens Sarah
Restricted stock units · derivative
2026-03-02 Option exercise 4,000 $0.00
Gheuens Sarah
Restricted stock units · derivative
2026-03-02 Option exercise 5,666 $0.00
Goff Brian
Common stock
2026-03-02 Option exercise 8,500 $0.00
Jones Cecilia
Restricted stock units · derivative
2026-03-02 Option exercise 5,303 $0.00
Jones Cecilia
Common stock
2026-03-02 Option exercise 5,666 $0.00
Burns James William
Restricted stock units · derivative
2026-03-02 Option exercise 5,666 $0.00
Jones Cecilia
Restricted stock units · derivative
2026-03-02 Option exercise 4,000 $0.00
Jones Cecilia
Restricted stock units · derivative
2026-03-02 Option exercise 5,666 $0.00
Burns James William
Common stock
2026-03-02 Sell 1,163 $28.96 33,680
Washburn Theodore James Jr
Common stock
2026-03-02 Sell 798 $28.96 23,110
Washburn Theodore James Jr
Common stock
2026-03-02 Option exercise 2,450 $0.00
Jones Cecilia
Common stock
2026-03-02 Option exercise 4,000 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 235 63,655,949
2025-12-31 239 63,739,725
2025-09-30 227 64,116,378
2025-06-30 216 57,983,666
2025-03-31 222 56,597,821
2024-12-31 228 56,384,299
2024-09-30 211 55,828,612
2024-06-30 208 56,020,658
2024-03-31 190 63,249,154
2023-12-31 171 60,081,460
2023-09-30 148 56,383,295
2023-06-30 155 56,685,141
Form 13F Holdings
Firm Period DFND Voting Shares
Assenagon Asset Management SA [2026-06-30] SOLE 103,955 103,955
Hennion & Walsh Asset Management Inc [2026-06-30] SOLE 33,574 33,574
Diversified Trust Co [2026-06-30] SOLE 0 23,948
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 696 17,959
Alaska Retirement Management Board [2026-06-30] SOLE 5,000 5,000
Merit Financial Group LLC [2026-06-30] OTR 0 4,365
Versant Capital Management Inc [2026-06-30] SOLE 2,001 2,001
Merit Financial Group LLC [2026-06-30] SOLE 10 1,191
Gamma Investing LLC [2026-06-30] DFND 538 538
City Holding Co [2026-06-30] SOLE 500 500
Farther Finance Advisors LLC [2026-06-30] SOLE 0 484
First Horizon Corp [2026-06-30] DFND 122 355
True Wealth Design LLC [2026-06-30] SOLE 0 306
Thurston Springer Miller Herd & Titak Inc [2026-06-30] SOLE 241 241
IFP Advisors LLC [2026-06-30] SOLE 233 233
First Horizon Corp [2026-06-30] OTR 0 87
Handelsbanken Fonder AB [2026-06-30] SOLE 0 26
JFS Wealth Advisors LLC [2026-06-30] SOLE 0 2
Fortitude Family Office LLC [2026-06-30] SOLE 2 2
Hughes Financial Services LLC [2026-06-30] SOLE 1 1
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com